Literature DB >> 11085668

Multiple eccrine spiradenomas in zosteriform distribution in a child.

S Gupta1, V K Jain, U Singh, S Gupta1.   

Abstract

A 9-year-old boy presented with asymptomatic papulonodular lesions on the left half of the chin of 3-years duration. On examination he had small papular lesions on the left chin varying in size from 1 to 5 mm. An additional lesion on the margin of the lip was 14 mm in diameter. The overlying skin was normal. Lesions were firm, nontender, and fixed to the skin. Histopathologic examination of the biopsy specimen revealed characteristic features of eccrine spiradenoma. A literature search produced reports of 10 cases of linear/zosteriform spiradenoma. Of these, five were in children or adolescents. We report this patient because of the rare occurrence of this presentation.

Entities:  

Mesh:

Year:  2000        PMID: 11085668     DOI: 10.1046/j.1525-1470.2000.017005384.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  4 in total

1.  Zosteriform spiradenoma with spiradenocarcinoma: A rare entity.

Authors:  Satish A Adulkar; Atul M Dongre; Uday S Khopkar; Raghuram Maddala; Prachi V Gole; Siddhi Chikhalkar
Journal:  Indian Dermatol Online J       Date:  2015-12

2.  Inexplicable Co- Existence of Eccrine Spiradenoma and Lichen Planus in an old Case of Basal Cell Carcinoma.

Authors:  A L Hemalatha; M S Lavanya; K Anoosha; K P Ashok; M Rajani Deepa
Journal:  J Clin Diagn Res       Date:  2015-01-01

3.  A rare case of multiple segmental eccrine spiradenomas.

Authors:  Laura Englander; Jason J Emer; Danielle McClain; Bijal Amin; Ryan B Turner
Journal:  J Clin Aesthet Dermatol       Date:  2011-04

4.  Immunohistochemical and electron microscopic studies of Langerhans cells in a case of multiple eccrine spiradenomas.

Authors:  Yuji Ohtsuki; Hisashi Ohtsuka; Atsushi Kurabayashi; Mitsuko Iguchi; Manabu Matsumoto; Tamotsu Takeuchi; Gang-Hong Lee; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2007-12-21       Impact factor: 2.309

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.